Chairwoman Song Joins the Fray Amid Management Interference Controversy
Showdown Over Board and Shareholders' Votes Looms at End of Month

The conflict over managerial control of Hanmi Pharmaceutical Group is reigniting. As the internal feud between major shareholder Shin Dongguk, Chairman of Hanyang Precision, and professional manager Park Jaehyun, CEO of Hanmi Pharmaceutical, intensifies, Song Youngsook, Chairwoman of Hanmi Group and the spouse of the late founder Lim Sungki, who had previously remained silent, has broken her silence and effectively voiced her support for CEO Park. With the so-called “four-party alliance,” formed during last year’s dispute over control, now moving toward dissolution, the regular general shareholders’ meeting scheduled for the end of this month is expected to become a critical turning point that will determine who leads the group going forward.


According to industry sources on March 6, Chairwoman Song issued an official statement the day prior, declaring her support for CEO Park’s leadership. She stated, “Rather than having the major shareholder intervene directly in management, it is desirable for Hanmi to provide sound direction while professional managers lead the company under the authority and responsibility entrusted to them.” She also made it clear that “Hanmi Pharmaceutical is a company that cannot be run solely by one individual holding all the power.” This is widely seen as a direct check on Chairman Shin’s unilateral actions, as he has recently expanded his influence and clashed with CEO Park.

Amid Hanmi Pharmaceutical Turmoil, Song Youngsook Backs Park Jaehyun... Proxy Battle Set for March Shareholders’ Meeting View original image

Chairwoman Song’s statement is also interpreted as a strategic move to secure the upper hand in terms of legitimacy, using the recent sexual misconduct scandal involving a senior executive as a catalyst. She expressed deep responsibility for not preventing the incident in advance and issued an apology to employees. By clearly distancing herself from Chairman Shin, who is embroiled in controversy for allegedly shielding the executive and improperly interfering in management, Song aims to claim the moral high ground of advancing governance and management transparency.


As a result, the “four-party alliance,” which was formed in 2024 by Chairwoman Song, Hanmi Pharmaceutical Group Vice Chairman Lim Juhyun, Chairman Shin, and private equity fund manager La Defense Partners, has effectively collapsed. The latest developments have highlighted irreconcilable differences among the parties, causing fractures in the unity that had barely been maintained. Former allies who once stood together as major shareholders are now targeting each other, leaving the group mired in unpredictable internal turmoil. A representative of Chairman Shin’s side commented, “Ahead of the shareholders’ meeting, the four-party alliance continues to meet and we hope the conflict does not escalate further.”


Ultimately, the fate of managerial control is expected to be decided at the shareholders’ meeting. A fierce vote is anticipated over the potential reappointment of CEO Park. Chairman Shin has steadily increased his stake, raising his total shareholding to 29.83%. The side of Chairwoman Song has secured a stable voting bloc of 25.58%, including shares held by the Lim Sungki Foundation.



Chairwoman Song’s camp plans to actively persuade the National Pension Service, which holds the casting vote with a 6.64% stake, as well as nearly 30% of minority shareholders, by appealing to the clear rationale of advancing corporate governance and protecting professional management independence. They calculate that if they emphasize both legitimacy and practical benefits to rally shareholder support, they stand a strong chance of winning this vote. The industry believes that this shareholders’ meeting will not just determine whether the CEO is reappointed, but could serve as a pivotal moment to completely reshape Hanmi Pharmaceutical Group’s mid- to long-term governance structure and real leadership control.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing